Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy

Overview of attention for article published in Nature Medicine, March 1999

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

patent: 6 patents
wikipedia: 2 Wikipedia pages

guideline: 1 clinical guideline source

Readers on

mendeley: 132 Mendeley

So far, Altmetric has seen 6 patents that reference this research output.

Methods of treatment of viral infection and uses of anti-HSC70 inhibitors

Grant US-11266675-B2

United States of America

08 Mar 2022

METHOD FOR PREDICTING PATIENT'S RESPONSE TO BIGLYCAN TREATMENT

Application EP-3026432-A2

European Patent Office

01 Jun 2016

Method and Materials for Use in Diagnosing Viral Myocarditis

Application US-20110097272-A1

United States of America

28 Apr 2011

Method and materials for use in diagnosing viral myocarditis

Grant US-7867476-B2

United States of America

11 Jan 2011

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 2 additional patents.